Gene · 948
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An alternative reverse genetics system for PRRS virus and its application to define the role of endocytic sorting signal in GP3 protein intracellular trafficking. | Front Microbiol | 2026 | 41883786 | PubTator, text mining | PubMed |
| Deletion of hepatic growth hormone receptor contributes to the pathogenesis of lean MAFLD by elevating CD36. | Life Metab | 2026 | 41847434 | PubTator, text mining | PubMed |
| Biochemical components of chicken primordial germ cells are modified by cryopreservation: original analysis by Fourier Transform Infrared (FTIR) microspectroscopy. | Poult Sci | 2026 | 41833113 | PubTator, text mining | PubMed |
| Human FGF1ΔHBS Gene Therapy as Treatment for Metabolic Dysfunction-Associated Steatohepatitis in ApoE-KO Mice. | Cells | 2026 | 41827821 | PubTator, text mining | PubMed |
| CD36-PPARγ-SPP1 axis mediates hepatocyte-macrophage coordination to drive MASLD-related liver fibrosis. | JHEP Rep | 2026 | 41810434 | PubTator, text mining | PubMed |
| Platelet desialylation, apoptosis, and T-lymphocyte-mediated immune dysregulation: unveiling the pathways of platelet clearance in platelet transfusion refractoriness. | Res Pract Thromb Haemost | 2026 | 41810335 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| Computational modelling of the equine arteritis virus GP5/M Dimer: Implications for immune evasion and virulence. | PLoS One | 2026 | 41805756 | PubTator, text mining | PubMed |
| Prognostic integration of tumor microenvironment and parthanatos-related genes in gastric cancer: a machine learning-driven risk model and immune landscape profiling. | Front Immunol | 2026 | 41798945 | PubTator, text mining | PubMed |
| Galactose tolerance in adults with classical galactosaemia. Considering the gaps. | Mol Genet Metab Rep | 2026 | 41798075 | PubTator, text mining | PubMed |
| Alterations in lipid metabolism and blood profile in gynecological cancers - potential strategies in diagnosis and treatment. | Front Physiol | 2026 | 41778199 | PubTator, text mining | PubMed |
| Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer. | Signal Transduct Target Ther | 2026 | 41775684 | PubTator, text mining | PubMed |
| Role of viral glycoprotein 2a (GP2a) in PRRSV infection. | Virology | 2026 | 41775077 | PubTator, text mining | PubMed |
| ATP1A1 enhances porcine reproductive and respiratory syndrome virus type 2 attachment and internalization. | mBio | 2026 | 41773865 | PubTator, text mining | PubMed |
| Association of cytokine levels with treatment duration and patient family history in Egyptian multiple sclerosis patients. | Sci Rep | 2026 | 41771986 | PubTator, text mining | PubMed |
| Point-of-care ultrasound improves the diagnosis of heart failure in patients with dyspnea in primary care. | Front Med (Lausanne) | 2026 | 41767524 | PubTator, text mining | PubMed |
| Effects of fatty acids and cholesterol on functions and behavior of bone marrow mesenchymal stem cells. | iScience | 2026 | 41767261 | PubTator, text mining | PubMed |
| Obesity and oxidative stress: potential mechanisms in endometrial disorders. | Front Endocrinol (Lausanne) | 2026 | 41757245 | PubTator, text mining | PubMed |
| Advances in aptamer technology for target-based drug discovery. | J Pharm Anal | 2026 | 41756020 | PubTator, text mining | PubMed |
| Functional Foods as Modulators of Epigenetic Mechanisms Affecting Metabolic Health in Adolescence. | Int J Mol Sci | 2026 | 41752200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/948/papers?page=2